B
Catalyst Pharmaceuticals, Inc. CPRX
$21.02 $0.150.72%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 28.26% 25.33% 23.23% 15.40% 81.98%
Total Other Revenue -- -- -- -- --
Total Revenue 28.26% 25.33% 23.23% 15.40% 81.98%
Cost of Revenue 119.72% -76.94% 14.94% 11.79% -583.31%
Gross Profit -31.01% 2,084.28% 24.81% 16.07% 305.67%
SG&A Expenses 5.13% 36.71% 43.44% 57.94% 198.38%
Depreciation & Amortization 3.15% 10.11% 10.08% 43.07% 1,461.90%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 14.67% -44.39% 29.46% 43.46% 129.92%
Operating Income 50.73% 236.90% 16.16% -23.82% 35.36%
Income Before Tax 58.82% 250.46% 15.00% -22.04% 41.50%
Income Tax Expenses 53.80% 283.56% 39.48% -24.93% 57.40%
Earnings from Continuing Operations 60.53% 242.65% 8.03% -21.28% 36.80%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 60.53% 242.65% 8.03% -21.28% 36.80%
EBIT 50.73% 236.90% 16.16% -23.82% 35.36%
EBITDA 42.23% 310.90% 15.22% -13.39% 61.81%
EPS Basic 42.91% 227.81% -2.87% -28.85% 34.09%
Normalized Basic EPS 39.29% 232.64% 7.61% -29.56% 27.98%
EPS Diluted 41.39% 220.69% 0.00% -26.92% 34.61%
Normalized Diluted EPS 40.95% 225.76% 9.15% -28.01% 30.38%
Average Basic Shares Outstanding 12.35% 11.60% 11.22% 10.65% 2.04%
Average Diluted Shares Outstanding 11.01% 17.68% 9.66% 8.26% 0.20%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings